Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says

by | Sep 25, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

Novo Nordisk’s blockbuster diabetes drug Ozempic may decrease the risk of opioid overdoses in certain patients, demonstrating its potential as an …

FEATURED